Drug intelligence / Profile preview

Touxie Qingfei Decoction

Development stage: Preclinical
Lead developer: Shenzhen Science and Technology Innovation Bureau
Administration: Oral

Overview

Touxie Qingfei Decoction is a Traditional Chinese Medicine (TCM) preparation being investigated for its potential to treat epidemic diseases, specifically COVID-19. Its therapeutic aim is to clear heat and detoxify the body, thereby reducing the progression of the disease from mild to severe stages. It is currently being studied in clinical trials by institutions such as the Science and Technology Foundation of Shenzhen City and Shenzhen Traditional Chinese Medicine Hospital.

Beyond the preview

Go deeper on Touxie Qingfei Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Touxie Qingfei Decoction.

Explore the full profile